कृपया अन्य खोज का प्रयास करें
Tissue Repair Ltd, a clinical stage biopharmaceutical company, developing advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia. It is developing TR-987, including Glucoprime technology for the treatment of chronic wounds, burns, and other complex wounds; and TR Pro+ for aftercare of minimally invasive cosmetic procedures, as well as other products for veterinary, new bandage, scaffold products, and other therapeutic indications. The company was incorporated in 2012 and is headquartered in Sydney, Australia.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Vaclav Vetvicka | - | - | Member of Scientific Advisory Board |
Bryan Gray | - | 2021 | Independent Non-Executive Director |
Michael Woodward | - | - | Member of Scientific Advisory Board |
Jack Theseus Lowenstein | 67 | 2021 | Independent Non-Executive Chair |
Tony Charara | - | 2012 | Co-Founder & Executive Director |
Thomas E. Serena | - | - | Member of Scientific Advisory Board |
Graham Edmund Kelly | 78 | - | Chief Scientific Advisor |
Mitchel P. Goldman | - | - | Member of Scientific Advisory Board |
Michael Silberberg | - | 2023 | Independent Non-Executive Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है